Augustine Lawlor
CIK 1262327 · Chief Operating Officer · last filed 2025-04-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AVNC price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 301
CAMBRIDGE, MA 02142
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. (LPTX) Delisted | Chief Operating Officer | 706,042 | $1.56 | $1.10M | $7.44M | 20 | 2025-04-01 |
| CBIO | Director | 0 | $11.84 | $0 | -$423.5K | 21 | 2023-09-01 |
| Cardiovascular Systems Inc (CSII) Delisted | Director | 0 | $20.00 | $0 | -$10.13M | 20 | 2023-04-27 |
| GLOBEIMMUNE INC (GBIM) Delisted | Director | 463,267 | — | — | $13.18M | 9 | 2016-03-18 |
| HUMAN GENOME SCIENCES INC (HGSI) Delisted | Director | 42,429 | — | — | $0 | 28 | 2012-08-01 |
| Altimmune, Inc. (PIP) Delisted | 10%+ Owner | 757,030 | — | — | $6.70M | 2 | 2010-11-05 |
| Molecular Templates, Inc. (THLD) Delisted | 10%+ Owner | 276,479 | — | — | $0 | 1 | 2009-10-07 |
| Cardiovascular Systems Inc (RDYN) Delisted | Director | — | — | — | $0 | 2 | 2008-05-08 |
| MiddleBrook Pharmaceuticals, Inc. (AVNC) Delisted | 10%+ Owner | 6,215,389 | — | — | $14.53M | 1 | 2007-04-13 |
Recent Filings · Page 2 of 11
106 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-08-09 | Cardiovascular Systems Inc (CSII) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-02 | CYPHERPUNK TECHNOLOGIES INC. (LPTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-17 | Cardiovascular Systems Inc (CSII) Delisted | Grant (A) | +1,222 | $0 | EDGAR |
| 2021-10-05 | CBIO | Grant (A) | +5,839 | $0 | EDGAR |
| 2021-08-11 | Cardiovascular Systems Inc (CSII) Delisted | Grant (A) | +1,710 | $0 | EDGAR |
| 2021-07-02 | CBIO | Grant (A) | +5,542 | $0 | EDGAR |
| 2021-05-28 | CYPHERPUNK TECHNOLOGIES INC. (LPTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-04-05 | CBIO | Grant (A) | +4,761 | $0 | EDGAR |
| 2021-02-12 | CYPHERPUNK TECHNOLOGIES INC. (LPTX) Delisted | Mixed | — | $0 | EDGAR |
| 2021-01-28 | CYPHERPUNK TECHNOLOGIES INC. (LPTX) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.